Atrial natriuretic peptide attenuates the development of pulmonary hypertension in rats adapted to chronic hypoxia.

To test the hypothesis that chronic infusion of atrial natriuretic peptide (ANP) instituted before hypoxic exposure attenuates the development of pulmonary hypertension in hypoxia adapted rats, ANP (0.2 and 1.0 microgram/h) or vehicle was administered intravenously via osmotic minipump for 4 wk begi...

Description complète

Détails bibliographiques

Publié dans:	J Clin Invest
Auteurs principaux:	Jin, H, Yang, R H, Chen, Y F, Jackson, R M, Oparil, S
Format:	Artigo
Langue:	Inglês
Publié:	American Society for Clinical Investigation 1990
Sujets:	Research Article
Accès en ligne:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC296394/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/2136863/ https://ncbi.nlm.nih.govhttps://doi.org/10.1172/JCI114400
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!